Open original FDA record ↗Recall record
- FDA identifier
- Z-0833-03
- Company in FDA record
- Baxter Healthcare Corp.
- FDA classification date
- May 15, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The dialysis treatment may be run without the bicarbonate due to an undetected bicarbonate pump stall following a sodium change.
Source facts
- Action
- Baxter sent recall letters dated 3/20/03 to the Medical Director and Hemodialysis Chief Technicians via first class mail on 3/20/03. The letters informed the accounts of the potential of running a treatment without bicarbonate due to an undetected bicarbonate pump stall following a sodium change, and provided instructions to change the B-A-alarm limits on the System 1000 Delivery Systems and confirm proper functionality after completing these changes. These changes will prevent undetected acid-only delivery in the event of a sodium level change
- Initiated
- 2003-03-20
- Root cause
- Other
- Terminated
- 2004-01-23
- Distribution
- The devices were distributed nationwide and internationally to Baxter subsidiaries in Argentina, Belgium, Bolivia, Brazil, Canada, Chile, China, Ecuador, Egypt, El Salvador, Guatemala, Honduras, Hong Kong, India, Mexico, Philippines, Singapore, South Korea, Thailand, Turkey, United Kingdom, Venezuela and Vietnam.
- Recall number
- Z-0833-03
- Recall status
- Terminated
- CDRH record ID
- 26530
- FDA classified
- 2003-05-15
- Recall event number
- 25818